Yes, they would. The large comprehensive cancer centres are the centres that see all those cancers, even when they're relatively rare. I can say that at Princess Margaret, there are 20,000 new patients per year who come there, so even rare cancers are seen by specialists, and there are opportunities to address them in groups.
For the rarest kinds of cancers—and when you start to talk about the individual differences in cancer, at the genetic level, this is why we need to do it at scale. Even in a place as big as Toronto or B.C. or Montreal, these institutes by themselves are not big enough to address those unique aspects of individual cancers. That drives the need to do this in a collaborative and shared way.